NSW Pharmaceutical Science Group

The NSW Pharmaceutical Science Group was established in 1959 to “promote the dissemination and exchange of scientific and technical knowledge, particularly related to the Pharmaceutical Sciences”.

The Group has pursued this objective by the regular organisation of seminars with a panel of expert presenters. The presentations address specific topics or themes as variously applying to production, quality assurance, laboratory, regulatory and R&D of therapeutic goods.


Upcoming Events

 To be advised.



Past Events

Expand to view available recordings and presentations

Expand AllCollapse All
  • Clinical Trials – Expertises, Resources, Collaborative Partnerships and Product Supply - Wednesday 5 October 2022 
  • Dr Duncan Macinnis, Director of Stakeholder Engagement (NSW/ACT), MTPConnect
    Clinical Trials in Drug Development
    Judy Bingham, Executive Director, Easington Pty Ltd 

    GMP and other documentary requirements and guidelines for APIs and dose form
    David Edmonds, former Principal, CMC Regulatory

    From Bench to Clinic – Translating a new therapeutic into a commercially viable product for clinical trial
    Prof Paul Young, CEO, AB Initio Pharma

    Manufacture and Quality Requirements of NMEs/APIs for Clinical Trials
    Dr Jurgen Lindner, Executive Secretary, APIMAA (Active Pharmaceutical Ingredient Manufacturers’
    Association of Australia)

    Specifications, Manufacture and Quality Requirements of Dose Form and Placebos for Clinical Trials
    Craig Rogers, Director, Syntro Health

    The TGA presentation is not available to be posted on this website.
    A recording of this webinar, not including the TGA content, may be found at 

  • Establishing and Maintaining Data Integrity - Tuesday 25 October 2022
  • Presenters 1 : Dr Tony Manderson, Director, Scientific Operations Management Section, TGA 


There are no records.


Chair - Mr Scott Colbourne
Secretary - Mr Scott Colbourne
Treasurer - Mr David Edmonds
Committee Member - Mrs Niesha Davis
Committee Member - Ms Ivon Diaz
Committee Member - Ms Annette Fordham
Committee Member - Dr William Glover
Committee Member - Dr Chen Lim
Committee Member - Dr Jurgen Lindner
Committee Member - Mr Denis Moore
Committee Member - Mrs Noor Salman Qamar
Committee Member - Mr Gonzalo Verges
Committee Member - Dr Nial Wheate
Committee Member - Mrs Colleen Wood

Become Connected


If you would like get connected with NSW Pharm Group please contact us


  Contact us


Article: Regulatory and Other Requirements in Drug Development


David Edmonds, December 2019.


This article describes how, in conjunction with good and comprehensive science, a knowledge of TGA/Regulatory requirements and guidelines at the earliest stages of drug discovery and development should enhance the quality of the drug development.


The article can be downloaded here.